Universe Pharmaceuticals INC
UPC
$5.94
-$1.15-16.22%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | 3.80% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | 3.80% | |||
| Cost of Revenue | 0.00% | 2.23% | |||
| Gross Profit | 0.00% | 6.57% | |||
| SG&A Expenses | 0.00% | 50.73% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.00% | 13.36% | |||
| Operating Income | 0.00% | -154.62% | |||
| Income Before Tax | 0.00% | -301.34% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 0.00% | -301.34% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.00% | -301.34% | |||
| EBIT | 0.00% | -154.62% | |||
| EBITDA | 0.00% | -271.70% | |||
| EPS Basic | 0.00% | -301.86% | |||
| Normalized Basic EPS | 0.00% | -304.93% | |||
| EPS Diluted | 0.00% | -301.86% | |||
| Normalized Diluted EPS | 0.00% | -304.93% | |||
| Average Basic Shares Outstanding | 0.00% | -0.11% | |||
| Average Diluted Shares Outstanding | 0.00% | -0.11% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||